Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
12/27/2019
Janssen Secured Chinese Approval of Psoriasis Drug Tremfya (Gussetizum...
12/26/2019
Sanofi Files NDA for the World's Atopic Dermatitis Biologic Dupilumab ...
12/26/2019
CStone Pharma to Submit NDA for Anticancer Pralsetinib Next Year
12/26/2019
China Lists Lemazolam for Regulation as Class 2 Psychotropic
12/25/2019
CDE Solicits Comments on Guidelines for Clinical Protocol of Biosimila...
12/23/2019
NMPA Issues the Technical Guidelines for Clinical Comparability Studie...
12/23/2019
BeiGene Announces Acceptance of a China sNDA for REVLIMID in Relapsed ...
12/23/2019
Chinese Medical Researcher Investigated for Smuggling Vials of Biologi...
12/23/2019
AZ's Triple-Combination Therapy Approved in China
12/23/2019
Amid Trade War, China Lowers Import Tariffs on 850 Products Including ...
12/23/2019
Roche Eyes China for Sarepta's DMD Gene Therapy
12/20/2019
Chi-Med Gets Priority Review for 'Surufatinib' in China
12/20/2019
Gilead Sciences Announces Chinese Approval of Chronic HCV Drug Vosevi
12/20/2019
InxMed Cleared to Initiate Phase I Trial for Anticancer FAK Inhibitor
12/20/2019
China's Largest Plasmid and Virus Facility from GenScript Operational
12/20/2019
TRACON, 3D Medicines and Alphamab Enter Partnership for Subcutaneous P...
12/20/2019
NHC Issues Clinical Application Guidelines for New Anticancers
12/20/2019
Wuxi Biologics and Convalife Form Partnership to Develop Innovative An...
12/19/2019
Genzyme's Orphan Drug Fabrazyme (Agalsidase Beta) Approved in China
12/19/2019
Van Andel to Pay $5.5M for Failing to Disclose Chinese Funding
12/19/2019
George Clinical and GDPH to Collaborate in Clinical Research
12/19/2019
Shanghai Launches New "Cell Factory" for Cancer Therapy
12/19/2019
Recent Announcement for A More Effective Intellectual Property Protect...
12/19/2019
PHIIC: Data Snapshots of Chinese Pharma Market 2013-2019E
12/19/2019
Performance Snapshots of HKSE-Listed Pre-profit Biotech Startups
12/19/2019
NHC Issues Notice to Facilitate Inventory and Use of Tender Prevailing...
12/19/2019
Shanghai Launches New Policy to Support Building of Research Hospitals
12/18/2019
Everest Medicines Announces Chinese Clinical Trial Approval of Nefecon...
12/18/2019
Moffitt Cancer Center CEO, Others Resign Over China Ties
12/18/2019
Abcodia and AstraZeneca China Form Strategic Alliance for Ovarian Canc...
Page:
199
/
720
Total number of articles:
21572
:
[First]
[<<]
[197]
[198]
[199]
[200]
[201]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit